---
title: "Propranolol - Hemangioma"
sidebar: mydoc_sidebar
permalink: db00571-mesh-d006391-1.html
toc: false 
---


Path ID: `DB00571_MESH_D006391_1`
{% include image.html url="images/db00571-mesh-d006391-1.png" file="db00571-mesh-d006391-1.png" alt="db00571-mesh-d006391-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D011433 | Propranolol | Drug |
| UniProt:P08588 | Beta-1 adrenergic receptor | Protein |
| UniProt:P07550 | Beta-2 adrenergic receptor | Protein |
| UniProt:P13945 | Beta-3 adrenergic receptor | Protein |
| UniProt:P09038 | Basic growth factor of fibroblasts (bFGF) | Protein |
| InterPro:IPR027928 | Vascular endothelial growth factor (VEGF) | GeneFamily |
| GO:0002016 | Renin-angiotensin-aldosterone system | BiologicalProcess |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| GO:0006915 | Apoptosis | BiologicalProcess |
| MESH:D006391 | Hemangioma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Propranolol | DECREASES ACTIVITY OF | Beta-1 Adrenergic Receptor |
| Beta-1 Adrenergic Receptor | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor (Vegf) |
| Vascular Endothelial Growth Factor (Vegf) | NEGATIVELY REGULATES | Renin-Angiotensin-Aldosterone System |
| Propranolol | DECREASES ACTIVITY OF | Beta-2 Adrenergic Receptor |
| Beta-2 Adrenergic Receptor | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor (Vegf) |
| Propranolol | DECREASES ACTIVITY OF | Beta-3 Adrenergic Receptor |
| Beta-3 Adrenergic Receptor | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor (Vegf) |
| Beta-1 Adrenergic Receptor | DECREASES ACTIVITY OF | Basic Growth Factor Of Fibroblasts (Bfgf) |
| Beta-2 Adrenergic Receptor | DECREASES ACTIVITY OF | Basic Growth Factor Of Fibroblasts (Bfgf) |
| Beta-3 Adrenergic Receptor | DECREASES ACTIVITY OF | Basic Growth Factor Of Fibroblasts (Bfgf) |
| Basic Growth Factor Of Fibroblasts (Bfgf) | NEGATIVELY REGULATES | Renin-Angiotensin-Aldosterone System |
| Renin-Angiotensin-Aldosterone System | PRECEDES | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Apoptosis |
| Apoptosis | CORRELATED WITH | Hemangioma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00571#mechanismofaction](https://go.drugbank.com/drugs/DB00571#mechanismofaction)
  - [https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action](https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry)

Reference: 
  - [https://go.drugbank.com/drugs/DB00571#mechanismofaction](https://go.drugbank.com/drugs/DB00571#mechanismofaction)
  - [https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action](https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry)

Reference: 
  - [https://go.drugbank.com/drugs/DB00571#mechanismofaction](https://go.drugbank.com/drugs/DB00571#mechanismofaction)
  - [https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action](https://en.wikipedia.org/wiki/Propranolol#Mechanism_of_action)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Propranolol#section=Pharmacology-and-Biochemistry)
